Study guide

15.3 Post-Procedural CIED Assessment, Device Follow-Up & Wound Care

Registered Cardiac Electrophysiology Specialist RCES

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Pre-Procedural Assessment & Patient Preparation

1.1 Procedure Room Preparation, Equipment Verification & Aseptic Readiness 1.2 Pre-Procedural Clinical Evaluation, Labs, Consents & The Universal Time-Out 1.3 Patient Identification, Transport, HIPAA & Procedural Documentation 1.4 Patient Monitoring Setup, Defibrillator Pads & Pre-Procedural CIED Interrogation 1.5 Vascular Access Planning, Skin Preparation & Sterile Draping

2 Chapter 2: Cardiac Anatomy, Conduction & Electrophysiologic Foundations

2.1 Cardiac Anatomy for the EP Lab: Chambers, Access Routes & Coronary Supply 2.2 The Cardiac Conduction System, Action Potentials & Ion Channel Physiology 2.3 Cardiac Vector Analysis, 12-Lead ECG Fundamentals & Axis Determination

3 Chapter 3: EP Lab Instrumentation, Connectology & Lab Safety

3.1 EP Recording System Architecture, Signal Amplification & Frequency Filters 3.2 Cardiac Stimulator Operation, Junction Box Routing & Noise Troubleshooting 3.3 Electrical Safety, Electrical Units, Electrocautery & Fire Safety 3.4 Radiation Safety Physics, ALARA Principles, Shielding & Dose Limits 3.5 Procedural Supplies, Catheter Inventory, Surgical Instrumentation & Wound Closure

4 Chapter 4: Intra-Procedural Imaging, Sedation & Physiologic Monitoring

4.1 Fluoroscopic Projections (RAO, LAO, AP) & X-ray Tube Optimization 4.2 Intracardiac Echocardiography (ICE) Principles, Views & Catheter Navigation 4.3 Non-Radiographic Imaging: Cardiac CT/MRI, Image Fusion & Ultrasound-Guided Access 4.4 Conscious Sedation Protocols, Airway Management & Hemodynamic Monitoring 4.5 Vital Signs, Normal Laboratory Values & Intra-Procedural Lab Monitoring

5 Chapter 5: EP Pharmacology, Anticoagulation & Emergency Drugs

5.1 Vaughan Williams Antiarrhythmic Classification & EP Electrophysiology 5.2 Diagnostic & Provocative Drugs: Adenosine, Isoproterenol, Epinephrine, Atropine 5.3 Sedation & Analgesia Pharmacology, Reversal Agents & Recovery Scoring 5.4 Heparin Protocol, ACT Monitoring & Emergency Reversal with Protamine 5.5 Oral Anticoagulants, Antiplatelets & Peri-Procedural Management 5.6 ACLS Algorithms & Emergency Medications in the EP Lab

6 Chapter 6: Catheter Navigation, Normal Electrograms & Baseline Intervals

6.1 Standard Diagnostic Catheter Positions & Fluoroscopic/Anatomical Landmarks 6.2 Intracardiac Electrogram Interpretation & Normal Baseline Intervals (PA, AH, HV) 6.3 His Bundle Electrogram Recording, Split His Potentials & Infranodal Conduction

7 Chapter 7: Programmed Electrical Stimulation & Refractory Periods

7.1 Pacing Stimulation Fundamentals, Capture Thresholds & Drive Trains 7.2 Refractory Period Determination (ERP, RRP, FRP) & Sinus Node Function Testing (SNRT, cSNRT) 7.3 AV Nodal Decremental Conduction & Dual AV Nodal Physiology

8 Chapter 8: Diagnostic Evaluation of Supraventricular & Ventricular Tachycardias

8.1 Narrow-Complex Tachycardias: Differential Diagnosis of AVNRT, AVRT & AT 8.2 Diagnostic Pacing Maneuvers: Entrainment, PPI-TCL, V-A-V vs V-A-A-V & His-Refractory PVCs 8.3 Wide-Complex Tachycardias & Ventricular Arrhythmia Mapping Criteria

9 Chapter 9: Bradyarrhythmias, AV Block & Atrial Arrhythmia Recognition

9.1 Bradyarrhythmias, AV Block Classification & Conduction System Disease 9.2 Atrial Fibrillation & Atrial Flutter: Classification, ECG Recognition & Stroke Risk

10 Chapter 10: 3D Electroanatomic Mapping & Ablation Biophysics

10.1 3D Electroanatomic Mapping Systems (Carto, EnSite, Rhythmia) Setup & Troubleshooting 10.2 Activation, Propagation & Bipolar Voltage Substrate Mapping 10.3 Ablation Biophysics: Radiofrequency, Cryoablation & Pulsed Field Ablation (PFA)

11 Chapter 11: Transseptal Access, Catheter Ablation Targets & Endpoints

11.1 Transseptal Puncture: Anatomy, Technique, Imaging Guidance & Complications 11.2 Catheter Ablation of AVNRT Slow Pathway & Accessory Pathways (WPW) 11.3 Cavotricuspid Isthmus (CTI) Ablation for Typical Atrial Flutter 11.4 Pulmonary Vein Isolation (PVI) for AFib & Ventricular Tachycardia Ablation

12 Chapter 12: Cardiac Implantable Electronic Devices: Implantation & Testing

12.1 Pacemaker & Transvenous ICD Implantation Techniques & Safety 12.2 Intra-Procedural Electrical Testing: Sensing, Pacing Thresholds, Impedance & DFT 12.3 Cardiac Resynchronization Therapy (CRT) & Conduction System Pacing (HBP, LBBAP)

13 Chapter 13: CIED Interrogation, Programming & Troubleshooting

13.1 NBG Pacemaker Codes, Pacing Modes & Timing Cycles 13.2 CIED Interrogation Workflow, Programmer Operation & Peri-Procedural Reprogramming 13.3 Interpreting & Conveying Interrogated Data: Diagnostics, Counters & Stored Episodes 13.4 Pacing & Sensing Malfunctions, Electromagnetic Interference & Temporary Pacing

14 Chapter 14: Specialized Devices, Extraction & Acute Procedural Emergencies

14.1 Subcutaneous ICD (S-ICD), Leadless Pacemakers & Left Atrial Appendage Closure 14.2 Transvenous Lead Extraction Tools, Techniques & Safety Precautions 14.3 Acute Procedural Emergencies: Perforation, Tamponade, Pericardiocentesis & Air Embolism

15 Chapter 15: Post-Procedural Care, Hemostasis & Complication Management

15.1 Femoral Hemostasis Techniques: Manual Compression, Figure-of-8 & Closure Devices 15.2 Post-Procedural Complications: Vascular Injury, AV Block, Esophageal Injury & Neurologic Deficits 15.3 Post-Procedural CIED Assessment, Device Follow-Up & Wound Care 15.4 Post-Procedure Patient Recovery, Discharge Education & Clinical Handover

15.3 Post-Procedural CIED Assessment, Device Follow-Up & Wound Care

Key Takeaways Explain This Topic AI

Task E1 requires obtaining and evaluating post-procedural data, and for a device patient that includes a full post-implant interrogation with documented thresholds, sensing, and impedances.

A post-implant chest radiograph confirms lead position and slack and rules out pneumothorax, which can present up to 48 hours after subclavian puncture.

First device follow-up occurs at 2-12 weeks, then every 3-12 months for a pacemaker and 3-6 months for an ICD, with remote monitoring recommended for all patients.

Ipsilateral arm restriction after implant limits abduction above shoulder level and heavy lifting for roughly 2-4 weeks to prevent lead dislodgement.

Any device restored from a procedural configuration must be verified before the patient leaves monitored care.

Last updated: September 2026

15.3 Post-Procedural CIED Assessment, Device Follow-Up & Wound Care

CCI's post-procedural duty ( E , 8% of the exam) includes obtaining and evaluating post-procedural data (E1) , providing patient education (E4) , performing the final patient assessment (E5) , and reporting and transfer of care (E6) . The knowledge list adds follow-up assessments of the CIED patient , wound assessment , wound healing , and wound closure .

  • 1. Immediate Post-Implant Assessment
  • The mandatory interrogation

Every device is fully interrogated after implantation, and the values become the baseline against which all future follow-up is compared:

  • Parameter What is documented
  • Thresholds Atrial and ventricular (and LV for CRT) capture threshold at a stated pulse width
  • Sensing P wave and R wave amplitudes
  • Impedance Pacing lead impedance for each lead; shock coil impedance for an ICD

Programmed parameters Final mode, rates, outputs, sensitivities, and for an ICD the detection zones and therapies

Battery Voltage and estimated longevity

For any device that was reprogrammed for the procedure — asynchronous mode for cautery, therapies suspended, MRI mode enabled — the restoration is verified and documented before the patient leaves monitored care . This is the closing half of the peri-procedural workflow and the step most often omitted.

The chest radiograph

A posteroanterior and lateral chest radiograph is obtained after implantation with two explicit objectives:

Confirm lead position and adequate lead slack — enough redundancy to accommodate arm movement and postural change without tension, but not so much that a loop can prolapse across the tricuspid valve.

Exclude pneumothorax and hemothorax , the principal acute complications of subclavian puncture.

Pneumothorax can present up to 48 hours after implant , so new dyspnea, pleuritic pain, or hypoxia in that window prompts repeat imaging rather than reassurance based on the immediate post-procedure film.

Acute complication surveillance

  • Complication Timing Signs
  • Pneumothorax 0-48 h Dyspnea, pleuritic pain, decreased breath sounds, hypoxia
  • Pocket hematoma 0-72 h Tense, expanding, fluctuant swelling

Lead dislodgement First days to weeks Loss of capture or sensing, threshold change, changed radiographic position

Cardiac perforation / tamponade Hours to days Hypotension, pulsus paradoxus, effusion, diaphragmatic pacing , rising threshold

  • Diaphragmatic stimulation Immediate to days Rhythmic hiccup or twitching synchronous with pacing
  • Venous thrombosis Days to weeks Ipsilateral arm swelling, collateral veins
  • Infection Days to months Fever, spreading erythema, purulent drainage, bacteremia

Twiddler's syndrome Weeks to months Patient manipulation rotates the generator, coiling and retracting the leads

Diaphragmatic stimulation deserves specific attention because it means different things depending on the lead: from a right ventricular lead it raises concern for perforation and warrants urgent evaluation; from a left ventricular coronary sinus lead it usually reflects proximity of the left phrenic nerve and is managed by reprogramming the pacing vector on a quadripolar lead rather than by repositioning.

2. The Follow-Up Schedule

  • Interval Purpose
  • Pre-discharge Confirm final programming, thresholds, sensing, impedance, wound
  • 2-12 weeks post-implant In-person wound check and reprogramming to chronic outputs as thresholds mature
  • Every 3-12 months (pacemaker) Remote or in-person
  • Every 3-6 months (ICD) Remote or in-person
  • At least annually In-person evaluation
  • Every 1-3 months near ERI Increased frequency as the battery approaches replacement

Remote monitoring is recommended for all device patients and provides earlier detection of lead failure, arrhythmia, and battery depletion than scheduled visits alone, with reduced inappropriate shocks and fewer in-person visits.

The 2-12 week visit exists for a specific physiologic reason: capture thresholds rise over the first weeks as an inflammatory and fibrotic capsule forms at the electrode-tissue interface, then fall and stabilize at a chronic value (a process blunted by steroid-eluting electrodes). Outputs programmed generously at implant are reduced at that visit to preserve battery life once the chronic threshold is known.

3. Wound and Pocket Care

Dressing and hygiene. The dressing typically stays dry and intact for 24-48 hours. The patient may then usually shower, but should not submerge the site in a bath, pool, or hot tub until the incision is fully healed, and should not scrub, apply ointment, or pick at adhesive strips or scabs.

What the patient must report immediately:

  • Fever or chills
  • Spreading redness , increasing warmth, or increasing pain after the first few days
  • Any drainage , particularly purulent, or drainage that appears after 48 hours
  • Increasing swelling or a tense, expanding pocket
  • Wound edges separating, or any part of the device becoming visible

Expected findings — mild bruising, a small firm ridge along the incision, and localized tenderness fading over the first week — are distinguished carefully in patient education from the alarm findings above, because unnecessary anxiety and dangerous complacency are both failures.

Two hard rules:

Never aspirate a pocket hematoma with a needle. It introduces organisms into a closed space containing prosthetic material. Tense or expanding hematomas are evacuated surgically under sterile conditions.

Erosion or exposure of any component mandates complete system extraction — generator and all leads. A device that has breached the skin is colonized and cannot be salvaged in place.

4. Activity Restriction and Education

Restriction Duration Rationale

No ipsilateral arm abduction above shoulder level ~2-4 weeks Prevents lead dislodgement before fibrous fixation

  • No lifting > ~5-10 lb with the ipsilateral arm ~2-4 weeks Same
  • Gentle range of motion encouraged From day 1 Prevents frozen shoulder from over-immobilization

No driving after ICD implant Varies by indication and jurisdiction — commonly ~1 week for primary prevention, longer after an arrhythmic event Syncope risk

Return to routine activity ~1-2 weeks for most non-strenuous activity —

The balance between restriction and mobilization is itself testable: complete immobilization for weeks is the wrong answer, because adhesive capsulitis is a common and disabling complication of over-restriction.

Core patient education content:

Carry the device identification card at all times , and present it at every medical or dental encounter, at airport security, and in any emergency.

Airport and retail security: inform staff and carry the card; walk through at a normal pace and do not linger in the gate; hand-wanding directly over the device is avoided.

Cell phones and magnets: keep phones, phone cases with magnets, wireless chargers, and smart-watch bands at least 15 cm (6 inches) from the generator; use the contralateral ear.

MRI: never assume the system is conditional — the treating radiology team must confirm it from the device record.

Household appliances, microwaves, and normal electronics are safe. Arc welding, large industrial motors, and high-power transmitters require occupational assessment.

ICD-specific: what a shock feels like, what to do after one shock with a return to feeling well (contact the clinic), and when to call emergency services (multiple shocks, a shock with ongoing symptoms, or loss of consciousness).

Remote monitoring: how to set up the transmitter, keep it powered and in range, and respond to alerts.

5. Reporting and Transfer of Care

Task E6 closes the procedure. The handover to the receiving unit is structured and includes, for a device patient:

Device type, manufacturer, model, serial numbers of the generator and every lead , and implant approach.

Pacing dependence status.

Final programmed mode, rates, and — for an ICD — whether therapies are on .

Post-implant threshold, sensing, and impedance values.

Chest radiograph status and result.

Access site and pocket findings, drainage, and dressing.

Arm restriction instructions and their duration.

Antibiotic and analgesic orders, anticoagulation plan and resumption timing.

Follow-up appointment and remote monitoring enrollment.

Any device left in a non-baseline configuration, stated explicitly with the plan for restoration.

The last item is the one that prevents harm. A verbal, closed-loop confirmation that "tachytherapy is ON" or "tachytherapy remains OFF and must be restored before discharge" is the difference between a routine recovery and an avoidable arrest.